OPA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.18089998785354E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.25059999999977E-05 |
Normal-vs-Stage2 |
1.69709999997547E-06 |
Normal-vs-Stage3 |
2.24265050974282E-14 |
Normal-vs-Stage4 |
6.9780847766765E-12 |
Stage1-vs-Stage2 |
3.826000E-02 |
Stage1-vs-Stage3 |
2.38970000010497E-07 |
Stage1-vs-Stage4 |
1.79495999999002E-05 |
Stage2-vs-Stage3 |
2.380600E-01 |
Stage2-vs-Stage4 |
1.788390E-01 |
Stage3-vs-Stage4 |
7.628600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.13560272296809E-11 |
Normal-vs-AfricanAmerican |
2.215800E-02 |
Normal-vs-Asian |
9.731900E-02 |
Caucasian-vs-AfricanAmerican |
4.532000E-02 |
Caucasian-vs-Asian |
4.225000E-01 |
AfricanAmerican-vs-Asian |
8.514400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.32667268468867E-14 |
Normal-vs-Female |
2.204500E-04 |
Male-vs-Female |
5.7611000000013E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.39940000038119E-07 |
Normal-vs-Age(41-60Yrs) |
2.29979999488705E-08 |
Normal-vs-Age(61-80Yrs) |
1.76839998200506E-09 |
Normal-vs-Age(81-100Yrs) |
2.721200E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.886300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.299400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.140800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.856800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.700800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.429200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.939000E-01 |
Normal-vs-Grade 2 |
1.03510000015739E-07 |
Normal-vs-Grade 3 |
1.63040025924488E-10 |
Normal-vs-Grade 4 |
1.63913327355658E-12 |
Grade 1-vs-Grade 2 |
3.618200E-02 |
Grade 1-vs-Grade 3 |
1.488310E-02 |
Grade 1-vs-Grade 4 |
3.535100E-03 |
Grade 2-vs-Grade 3 |
3.269600E-02 |
Grade 2-vs-Grade 4 |
3.73770000000606E-05 |
Grade 3-vs-Grade 4 |
7.899900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.27429999999762E-05 |
Normal-vs-ccB subtype |
1.62525548574877E-12 |
ccA subtype-vs-ccB subtype |
1.95500005073512E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.58499904709697E-11 |
Normal-vs-N1 |
9.81639999952932E-07 |
N0-vs-N1 |
8.698000E-02 |
|
|